menu
    • menu

    Company profile for Code Bio

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Code Bio was founded on the belief that more can be done for people living with debilitating genetic diseases. We are driven by the potential of our transformative technology to treat the untreatable and cure the incurable. Code Bio is developing highly targeted genetic medicines with its proprietary, novel, multivalent, synthetic DNA delivery platform, 3DNA®, which has been engineered to overcome many of the challenges inhe...
    Code Bio was founded on the belief that more can be done for people living with debilitating genetic diseases. We are driven by the potential of our transformative technology to treat the untreatable and cure the incurable. Code Bio is developing highly targeted genetic medicines with its proprietary, novel, multivalent, synthetic DNA delivery platform, 3DNA®, which has been engineered to overcome many of the challenges inherent with the delivery of genetic medicines. 3DNA offers unparalleled tissue and cell targeting specificity, improved bioavailability, capability to deliver large genetic payloads, potential ability to re-dose.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Code BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2801 Sterling Drive Hatfield, PA 19440
    Telephone
    Telephone
    +1 312-961-2502
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.codebiotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/code-biotherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Code Biotherapeutics Names Alex S. Tracy as CTO
    Code Biotherapeutics Names Alex S. Tracy as CTO

    14 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221114005065/en/Code-Biotherapeutics-Names-Alex-S.-Tracy-PhD-as-Chief-Technical-Officer

    BUSINESSWIRE
    14 Nov 2022
    Share Share
    Code Biotherapeutics Names Alex S. Tracy, PhD, as Chief Technical Officer
    Code Biotherapeutics Names Alex S. Tracy, PhD, as Chief Technical Officer

    14 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221114005065/en

    BUSINESSWIRE
    14 Nov 2022
    Share Share
    Code Bio launches with $75M to reinvent genetic medicine
    Code Bio launches with $75M to reinvent genetic medicine

    08 Jun 2022

    // A. Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/code-launches-75m-reinvent-genetic-medicine-rare-and-not-so-rare-diseases

    A. Armstrong FIERCEBIOTECH
    08 Jun 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search